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This methodological study aimed to evaluate the predictive validity of the Braden scale in 
critical care patients. The study was conducted in four intensive care units of a general 
private hospital. After approval of the project by the Hospital Ethics Committee, during six 
months, adult patients admitted to ICUs with a Braden score ≤18 and without PU were 
assessed upon admission and at 48-hours intervals as long as the patient remained at risk 
or until the development of PU, patients’ discharge, death or transfer from the ICU. The 
cut-off scores of the Braden scale in the first, second and third assessments were 12, 13 
and 13, respectively. Sensitivity was 85.7%, 71.4% and 71.4% and specificity was 64.6%, 
81.5% and 83.1%, respectively. Areas under the ROC curves revealed very good accuracy 
for the cut-off scores. The Braden cut-off score 13 in the third assessment showed the best 
predictive performance in critical care patients.
Descriptors: Pressure Ulcer; Intensive Care; Predictive Value of Tests; Sensitivity and 
Specificity.
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Validade preditiva da escala de Braden para o risco de desenvolvimento 
de úlcera por pressão, em pacientes críticos
Este estudo metodológico foi desenvolvido em quatro unidades de terapia intensiva de 
um hospital geral, com o objetivo de avaliar a validade preditiva da escala de Braden 
em pacientes críticos. Após aprovação do projeto pelo Comitê de Ética em Pesquisa, da 
instituição, durante seis meses, pacientes adultos com escore total de Braden ≤18 e 
sem úlceras por pressão (UP) foram avaliados na admissão e a cada 48 horas, enquanto 
permaneceram em risco ou até o desenvolvimento de UP, alta, morte ou transferência da 
UTI. Os escores de Braden 12, 13 e 13, respectivamente na primeira, segunda e terceira 
avaliação apresentaram sensibilidade de 85,7, 71,4 e 71,4% e especifidade de 64,6, 
81,5 e 83,1%. As áreas sob a curva ROC (Receiver Operating Characteristics) revelaram 
acurácia muito boa para os escores de corte obtidos. O escore de corte da escala de 
Braden igual a 13, na terceira avaliação, apresentou a melhor performance preditiva em 
pacientes críticos. 
Descritores: Úlcera por pressão; Cuidados intensivos; Valor Preditivo dos Testes; 
Sensibilidade e Especificidade.
Validez predictiva de la Escala de Braden para el riesgo de úlceras por 
presión en pacientes críticos
Se tuvo por objetivo evaluar la validez predictiva de la Escala de Braden en los pacientes 
críticos. Se trata de un estudio metodológico, en cuatro unidades de cuidados intensivos 
de un hospital general. Después de la aprobación del proyecto por el Comité de Ética 
de la Institución, durante seis meses, los pacientes adultos con puntuación total de 
Braden ≤18 y sin úlceras por presión (UP) fueron evaluados en la admisión y a cada 48 
horas, mientras permanecieron en riesgo o hasta: el desarrollo de UP, el alta, la muerte 
o removidos de la UCI. Las puntuaciones de Braden 12, 13 y 13, respectivamente en 
la primera, segunda y tercera evaluaciones presentaron sensibilidad de 85,7%, 71,4% 
y 71,4% y especificidad de 64,6%, 81,5% y 83,1% respectivamente. Las área bajo 
las curvas ROC muestrearon muy buena precisión de las puntuaciones obtenidas. Se 
concluye que la puntuación de Braden 13, en la tercera evaluación, presentó el mejor 
desempeño predictivo en los pacientes críticos.
Descriptores: Úlcera por Presión; Cuidados Intensivos; Valor Predictivo de las Pruebas; 
Sensibilidad y Especificidad.
Introduction
Intensive care units (ICUs) receive patients with 
single or multiple organ failure, who often require 
life support measures like mechanical ventilation, 
continuous sedation and vasoactive drugs, in addition 
to multiple types of devices, such as catheters, drains, 
probes and immobilizers. These measures significantly 
impair one of the most important mechanisms for the 
maintenance of skin integrity, i.e. bed mobility, making 
patients highly vulnerable to the development of 
pressure ulcers (PU)(1-2).
The National Pressure Ulcer Advisory Panel(3) defines 
a PU as an area of localized damage to the skin and/
or underlying tissue, generally located above a bone 
prominence, which is caused by pressure or pressure 
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in combination with shear and friction. Various factors 
have been associated with the development of PU(3). 
Specifically in the case of ICU patients, these factors 
include nutritional deficits, moisture, artificial ventilation, 
circulatory disturbances, altered tissue perfusion and, 
mainly, increased exposure to pressure, age, sepsis, 
prolonged hospitalization, some chronic diseases or 
conditions like diabetes, nephropathies and spinal cord 
injury and emergency admission(1-2,4).
In the international scenario, the implementation 
of guidelines for PU prevention has brought down their 
incidence in critical care patients from 43% to a current 
incidence of 28%(2). In a recent literature review, 
however, the authors found higher incidence rates, from 
38% to 124%, in the studies examined(5). In Brazil, 
concern regarding the incidence of PU in ICU patients 
has also been increasing, with studies conducted in Rio 
de Janeiro and São Paulo, reporting incidences from 
26.83% to 62.5%(6-8).
Risk assessment scales for PU development have 
been studied and implemented in vulnerable groups or 
groups more exposed to skin integrity alterations. A 
study(9) reported the existence of more than 40 scales, 
but only six have been tested for predictive validity. 
Norton, Gosnell, Waterlow, Braden and Bergstrom 
significantly contributed to these studies(10-11).
The Braden scale was published in 1987, and 
has mainly been used in the United States(11). This 
instrument was adapted and validated for the Brazilian 
culture in 1999(12) and has been applied since then by 
some institutions in Brazil. The Braden scale consists of 
six subscales: sensory perception, moisture, activity, 
mobility, nutrition and friction/shear. The total score can 
range from 6 to 23 and patients are classified as follows: 
very high risk (score ≤ 9), high risk (score ranging from 
10 to 12), moderate risk (score ranging from 13 to 14), 
low risk (score ranging from 15 to 18), and no risk (score 
ranging from 19 to 23)(13).
In their initial study(11), the authors found a 
sensitivity and specificity of 83% and 64%, respectively, 
for cut-off score 16. More recently, the same authors 
recommended score 18 as more appropriate, so that 
elderly patients as well as physiologically unstable white 
and black patients could be included(14). Since then, 
many research groups worldwide have tried to establish 
the best cut-off score of the Braden scale, i.e. to define a 
score that best indicates risk for the development of PU. 
In 2003, it was concluded that the cut-off scores authors 
presented could not be precisely reproduced in all units, 
a fact that supported the need for further studies, 
evaluating the sensitivity and specificity of the scale in 
different areas, based on the distinct characteristics of 
the patients in each specialty(15).
Since ICU patients have peculiar characteristics and 
in view of the scarcity of Brazilian studies evaluating the 
performance of the Braden scale in general, the aim of 
the present study was to analyze the predictive validity 
of the Braden scale in critical care patients.
Methods
A methodological study was conducted, using the 
database from the study by Serpa and Santos(16). In the 
original study, the data were collected at four ICUs (two 
neurology ICUs, one cardiology ICU and one general 
ICU, comprising a total of 80 beds) of a large, nonprofit 
charitable general hospital. Data were collected between 
January and July 2006. Although the nursing staff of 
the hospital uses the nursing care process, there are no 
institutional protocols for the prevention and treatment of 
PU and risk assessment scales are not used routinely.
Data were collected after approval of the research 
project was obtained from the Institutional Ethics 
Committee. After being invited to participate in the 
study, the patients or their legal representative received 
detailed information about the study objective and, 
after agreeing to participate, signed two copies of the 
informed consent form, with one copy remaining with 
the patient and the other with the researchers.
All patients hospitalized at the selected ICUs during 
the period of data collection were evaluated and those 
complying with the following criteria were included in 
the sample: age ≥ 18 years, absence of PU in the first 
assessment, hospitalization for a minimum period of 
24h and a maximum period of 48h, a total Braden score 
≤ 18, and consent to participate in the study. According 
to the criteria of the original study, patients with chronic 
renal failure, patients under dialysis for more than one 
month and patients with liver insufficiency accompanied 
by ascites were excluded. From a total of 82 patients 
admitted to ICUs consecutively during six months, 72 
composed the final sample according to the inclusion and 
exclusion criteria. Seven patients were discharged, two 
refused to participate and one died before completing 
data collection.
Two instruments were used for data collection: the 
first consisted of socio-demographic and clinical data 
and was applied in the first assessment; and the second 
contained the validated Braden scale(12) and was applied 
in the first assessment and at 48-h intervals, as long 
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as the patient remained at risk or until the following 
outcomes: development of PU, discharge, death or 
transfer from the ICU. Only data from patients with at 
least three consecutive assessments were used for the 
analyses.
Since the beginning of the study, all healthcare 
team members were informed about patients who were 
at risk of developing PU and preventive measures were 
the responsibility of the institution. Once a PU was 
detected, the same procedure was adopted and the 
nursing staff was responsible for the adoption of the 
necessary therapeutic measures, without interference 
from the researchers.
To analyze the predictive validity of the Braden 
scale, sensitivity and specificity of the cut-off scores 
were calculated using receiver operating characteristic 
(ROC) curves, in addition to their likelihood ratios.
When interpreting the results of a diagnostic test as 
the probability of occurrence of a disease/phenomenon, 
the positive predictive value of the Braden scale indicates 
the probability of a patient to develop PU when classified 
as being at risk by the scale, whereas its negative 
predictive value refers to the probability of a patient not 
to develop PU when classified as not being at risk by 
the scale.
Authors(17) defined sensitivity as the proportion of 
individuals with a positive test who develop a disease, 
and specificity as the proportion of individuals with a 
negative test who do not develop a disease.
The ROC curve is a graphic plot of true positive 
values (sensitivity) on the ordinate and false positive 
values (1 – specificity) on the abscissa as a function 
of each cut-off point. Tests with a good discriminatory 
power are concentrated in the upper left corner of the 
ROC curve. There is an approximately linear quantitative-
qualitative relationship between the area under the 
curve (AUC) and accuracy, which can be classified as 
follows: excellent (0.80-0.90), very good (0.70-0.79), 
good (0.60-0.69), and poor (0.50-0.59)(17-18).
The likelihood ratio is another method used to 
correlate specificity and sensitivity. In the present study, 
the likelihood ratio was used to express the higher (or 
lower) chance of finding a PU in patients at risk when 
compared to those classified as not being at risk. A 
positive likelihood ratio (LR+) of the Braden scale refers 
to the ratio between the proportion of patients who 
develop PU and who are classified as being at risk and 
the proportion of patients who do not develop PU and 
who are classified as being at risk. A negative likelihood 
ratio (LR-) of the Braden scale is obtained when the result 
of the test is negative, i.e. the proportion of patients 
who develop PU and who are not classified as being at 
risk divided by the proportion of patients without PU and 
who are not classified as being at risk(18). These results 
are represented by Fagan Nomograms.
MS Excel software, version 2000, was used to 
construct the database, SPSS for Windows, version 
13.0, for statistical analyses and elaboration of the 
graphs, and MS Word, version 2003, to construct the 
tables. P-values below 5% were considered significant. 
The patients’ socio-demographic and clinical data (age, 
days of hospitalization, Braden score) were submitted to 
descriptive statistics.
Results
Out of 72 patients, 48 (66.7%) were men and 
the average age was 60.9 ± 16.5 years; 72.2% of the 
patients were classified as surgical. The minimum length 
of stay was 6 days and 20.8% of the patients were 
hospitalized for more than 31 days, mean 17.1 ± 9.0 
days. The most frequent diseases were related to the 
cardiovascular system (83.3%).
Initial evaluation classified the patients of the 
sample as low risk (30.5%), moderate risk (40.3%) and 
high risk (29.2%). Eight patients developed PU, with an 
incidence of 11.1%. PU were diagnosed since day 2 of 
hospitalization and were classified as stage I (42.9%) 
and stage II (57.1%).
A cut-off score 12 was identified in the first 
assessment, which showed 85.7% sensitivity and 64.6% 
specificity. In the subsequent two assessments, cut-off 
score 13 was obtained, with a sensitivity of 71.4% in the 
two assessments and specificity of 81.5% and 83.1% in 
the second and third assessment, respectively (Table 1).
Table 1 - Predictive values of the Braden scale cut-off scores in critical care patients, according to the assessment
Cut-off Sensitivity Specificity PPV NPV AUC(95%CI) + LR(95%CI) – LR(95%CI)
1st Assessment 12 85.7% 64.6% 20.7% 97.7% 78.8 (0.29-1 ) 2.42 (1.55-379) 0.22 (0.04-1.37)
2nd Assessment 13 71.4% 81.5% 29.4% 96.4% 78.9 (0.27-1) 3.87 (1.93-7.74) 0.35 (0.11-1.14)
3rd Assessment 13 71.4% 83.1% 31.3% 96.4% 80 (0.28-1) 4.22 (2.07-8.62) 0.34 (0.11-1.12)
PPV: positive predictive value; NPV: negative predictive value; AUC: area under the ROC curve; + LR and – LR: positive and negative likelihood ratio, 
respectively; 95%CI: 95% confidence interval.
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Analysis of the AUC showed excellent accuracy 
(0.8) in the third assessment and very good accuracy in 
the first and second assessment (0.78). All of the three 
curves showed a good discriminatory power (Figure 1).
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Figure 1 - ROC curves of the Braden scale cut-off scores in critical care patients, according to the assessment
LR+ was higher in the third assessment, with 
patients with score 13 presenting a 4.22 times higher 
chance of developing PU, compared to a 3.87 and 2.42 
times higher chance in the second and first assessment, 
respectively. The lowest LR- was observed in the first 
assessment (0.22) and the highest in the second 
assessment (0.35). Thus, in the third assessment, using 
score 13, the probability of developing PU was 31% 
when the test was positive and 4% when the test was 
negative. In the other assessments, the cut-off scores 
yielded lower probabilities of 29% and 21% for positive 
tests and 4% and 2% for negative tests in the second 
and first assessments, respectively (Figure 2).
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Figure 2 - Fagan nomograms of the Braden scale cut-off scores in critical care patients, according to the 
assessment
Discussion
PU are a socioeconomic and educational problem 
that has an important financial impact, with their 
prevention being less costly than their treatment. PU 
treatment ranks third among the most expensive health 
treatments, less expensive only than cancer treatment 
and heart surgery(19). In addition, when the patient 
develops a PU, the nursing team becomes intensive, 
showing an increase by about 50%. Thus, the prevention 
of PU is of primary relevance for patient care, with 
consequent benefits for the health system(12,20-21).
In order to prevent the development of PU and 
optimize resources and measures, risk assessment 
scales have been studied in detail worldwide(22-23), 
and also more timidly in Brazil(12). In these studies, 
sensitivity and specificity vary, resulting in different 
cut-off scores, mainly, as expected, when considering 
different specialties. These differences between cut-off 
scores are due to extrinsic and intrinsic characteristics 
of the specific patient groups, a fact that motivated the 
present investigation regarding the predictive validity 
of the Braden scale applied to critical care patients in 
Brazil.
Similar to our findings, other Brazilian authors(12) 
found a higher balance between sensitivity (52%) and 
specificity (80%) for critical care patients when score 13 
was used in the third assessment. The same score was 
obtained, investigating 186 patients from a neurology 
ICU, which classified 41.4% of the patients as being at 
risk in the first assessment, with a sensitivity of 91.4%, 
a positive predictive value of 27.3% and 1.8% of false-
negative results(24).
In another study(25), score 14 was also identified in 
337 patients submitted to heart surgery from the first till 
the third postoperative day during ICU hospitalization. 
This score showed the best performance on the third 
day, with 57.1% sensitivity and 92% specificity.
The frequency of application of the Braden scale 
continues to be a controversial issue. Although Waters(15) 
recommended its application upon admission and 48 
hours later, no consensus is available for intensive 
care patients. In its most recent revision about PU 
Prevention, the National Pressure Ulcer Advisory Panel 
(NPUAP)(26) recommended that institutional protocols of 
risk assessment and re-assessment should be developed 
according to the characteristics of the clinical areas 
where the patient is attended.
Restrictions of mobility, the presence of incontinence 
and nutritional status are rarely identified upon admission 
to the ICU. Thus, the cut-off score can be established 
in subsequent assessments, like in the present study 
and in another research(25). Applying the Braden scale at 
24-h intervals seems to be reasonable in view of critical 
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care patients’ frequent instability and the identification 
of a subsequent assessment as one of the best PU risk 
predictors in ICUs. In a recent literature review, the 
author stated that the ideal time for this evaluation 
varies according to the characteristics of the patients. 
In general, the first assessment should be performed 72 
h after admission, when the risk for the development of 
PU is elevated(27).
In the present study, considering all three consecutive 
assessments, score 13 in the third assessment obtained 
the most adequate predictive values, showing the best 
balance between sensitivity and specificity, and excellent 
accuracy and best LR, in agreement with other studies’ 
findings(12,24-25). These results confirm score 13 as the 
best to identify the risk for the development of PU in 
critical care patients.
Limitations and recommendations
Despite the prospective character of the present 
study, including rigorous and controlled data collection, 
limitations were related mainly to the number of ICU 
involved and the fact that they belonged to a single 
hospital.
In spite of its limitations, the study contributes 
with important data to the national and international 
literature by confirming or contrasting obtained results, 
using the same tool. On the other hand, it adds a new 
statistical strategy to analyze the predictive validity of 
risk assessment scales, which was the LR.
Further studies are necessary to analyze the 
Braden scale’s performance in a bigger sample, in 
different ICUs and according to specialty, such as bed 
immobility, a characteristic of neurology and trauma 
units, nutritional deficits in surgery and digestive tract 
units, and circulatory involvement in cardiology units, 
among others.
Conclusion
In the present study, the Braden cut-off score 13 
in the third assessment showed the best predictive 
performance in critical care patients.
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